In addition, we confirmed the breakpoints of the fusions in the genomic DNA in six of 12 primary leukemia samples either by Sanger sequencing (Appendix Fig S2; three patients) or by MLPA analysis for SIL‐TAL1 fusions (Dataset EV2a; three patients). This evidence concerns the gene TAL1 and leukemia.